openPR Logo
Press release

Oligonucleotide Synthesis Market to Garner US$ 3,971.72 Mn by 2027 with Leading Vendors: Nuclera Nucleics, Camena Bioscience, Synthomics, Ansa Biotechnologies, Helixworks, Iridia, Keasling Laboratories

09-07-2021 01:45 PM CET | Health & Medicine

Press release from: The Insight Partners

Oligonucleotide Synthesis Marke

Oligonucleotide Synthesis Marke

The global oligonucleotide synthesis market accounted to US$ 1,584.16 Mn in 2018 and is expected to grow at a CAGR of 11.1% during the forecast period 2019 - 2027, to account to US$ 3,971.72 Mn by 2027.

Oligonucleotides have many applications in research, diseases diagnosis, therapeutics, forensic, drug discovery, agriculture and many more. Oligonucleotides are used in many biological and forensic applications as sequence-specific binding agents can help in identifying presence of a specific target DNA sequence.
Synthetic oligonucleotides are short stretches of single stranded DNA fragments assembled by chemical synthesis. There is hardly a field in biology in which synthetic DNA has not been used or does not have the potential to be used. The main reason for such a turnabout is the simultaneous developments of methods for the rapid and efficient synthesis of oligonucleotides and the advent of molecular biology techniques. Researchers are also using oligonucleotides to produce more efficient, greener chemical synthesis. By assembling oligonucleotides together into longer fragments that encode synthetic genes, bacteria or yeast cells can be instructed to produce specific enzymes (a type of protein).

Oligonucleotides has tremendous potential for treating wide range of medical conditions. They enable the development of therapeutics as the malfunctioning genes can be targeted, manipulated, silenced and/or modulated. Ionis Pharmaceuticals has dedicated its existence to oligonucleotide therapeutic development, particularly antisense oligonucleotide (ASO) therapeutics. Thus, the promising potential of synthesized oligonucleotides in various fields drives the market growth.

(**Note: The sample of this report is updated with COVID-19 impact analysis**)

To Know How COVID-19 Pandemic Will Impact Global Oligonucleotide Synthesis Market | Get a Sample Copy of Report, Click Here:
https://www.theinsightpartners.com/sample/TIPBT00002549/?utm_source=OpenPR&utm_medium=10411

Top key vendors:
• Molecular Assemblies
• Twist Biosciences
• Evonetix
• DNA Script
• Nuclera Nucleics
• Camena Bioscience
• Synthomics
• Ansa Biotechnologies
• Helixworks
• Iridia
• Keasling Laboratories

OLIGONUCLEOTIDE SYNTHESIS - MARKET SEGMENTATION

By Product
• Synthesized Oligonucleotides
o Primers
o Probes
o Large-Scale Synthesis Oligonucleotides
o Others
• Reagents
• Equipment

By Application
• Research
• Diagnostics
• Therapeutics

By End User
• Academic Research Institutes
• Pharmaceutical & Biotechnology Companies
• Diagnostic Laboratories
• Other End Users

The regional analysis covers:
• North America (U.S. and Canada)
• Latin America (Mexico, Brazil, Peru, Chile, and others)
• Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, Luxembourg)
• Eastern Europe (Poland, Russia)
• Asia Pacific (China, India, Japan, ASEAN, Australia and New Zealand)
• Middle East and Africa (GCC, Southern Africa, North Africa)

North America, Latin America, Asia-Pacific, Africa, and Europe have been examined on the basis of different leading key players. The business profiles of several top-level companies have been profiled to get informative data for making further decisions in the businesses. The study estimates the factors that are driving or hampering the growth of the industries.

Purchase a copy of the report @
https://www.theinsightpartners.com/buy/TIPBT00002549/?utm_source=OpenPR&utm_medium=10411

The report highlights the risks and challenging factors which has been faced by different stakeholders and new entrants in the Oligonucleotide Synthesis Market. Additionally, it offers a closer and analytical look at numerous companies that strive for the highest market shares. The report also elaborates on the global opportunities and ways to enlarge the businesses globally. It presents the scope of this Global Market in the developing and developed regions. It also covers how the concept of this Oligonucleotide Synthesis Market is giving new opportunities for increasing global customers rapidly. This informative report further makes use of graphical presentation techniques such as graphs, tables, charts and pictures.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oligonucleotide Synthesis Market to Garner US$ 3,971.72 Mn by 2027 with Leading Vendors: Nuclera Nucleics, Camena Bioscience, Synthomics, Ansa Biotechnologies, Helixworks, Iridia, Keasling Laboratories here

News-ID: 2384324 • Views:

More Releases from The Insight Partners

Transfection Reagents and Equipment Market is anticipated to record a CAGR of 7.8% from 2022 to 2030
Transfection Reagents and Equipment Market is anticipated to record a CAGR of 7. …
The Transfection Reagents and Equipment Market is witnessing significant growth due to rising adoption of genetic engineering technologies across research, biopharmaceutical manufacturing, and advanced therapeutic development. Check valuable insights in the Transfection Reagents and Equipment Market report. You can easily get a sample PDF of the report - https://www.theinsightpartners.com/sample/TIPHE100001124?utm_source=OpenPr&utm_medium=10457 According to recent industry assessments, the transfection reagents and equipment market is expected to grow from US$ 1,170.79 million in 2022 to US$
5G Services Market Growth is expected at CAGR of 57.4% during 2023-2031.
5G Services Market Growth is expected at CAGR of 57.4% during 2023-2031.
Global 5G Services Market 2031 Report give our customers an exhaustive and top to bottom examination of 5G Services Market alongside its key factors, for example, market diagram and rundown, pieces of the pie, restrictions, drivers, local examination, players, serious elements, division, and considerably more. The 5G Services Market information introduced inside this report is acquired dependent on a few strategies, for example, PESTLE, Porter's Five, SWOT examination, To
Traffic Management Market Growth is expected at CAGR of 11.7% from 2025 to 2031.
Traffic Management Market Growth is expected at CAGR of 11.7% from 2025 to 2031.
Global Traffic Management Market 2031 Report give our customers an exhaustive and top to bottom examination of Traffic Management Market alongside its key factors, for example, market diagram and rundown, pieces of the pie, restrictions, drivers, local examination, players, serious elements, division, and considerably more. The Traffic Management Market information introduced inside this report is acquired dependent on a few strategies, for example, PESTLE, Porter's Five, SWOT examination, To
Automotive Battery Management System Market Growth is expected at CAGR of 17.6% from 2025 to 2031..
Automotive Battery Management System Market Growth is expected at CAGR of 17.6% …
Global Automotive Battery Management System Market 2031 Report give our customers an exhaustive and top to bottom examination of Automotive Battery Management System Market alongside its key factors, for example, market diagram and rundown, pieces of the pie, restrictions, drivers, local examination, players, serious elements, division, and considerably more. The Automotive Battery Management System Market information introduced inside this report is acquired dependent on a few strategies, for example, PESTLE,

All 5 Releases


More Releases for Oligonucleotide

Increasing Cancer Epidemic Driving Growth In The Oligonucleotide Therapy Market: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Oligonucleotide Therapy Market Size Growth Forecast: What to Expect by 2025? The market size for oligonucleotide therapy has been swiftly expanding in the past few years. Projected growth is from $5.61 billion in 2024 to $6.2 billion in 2025, indicating a compound annual growth rate (CAGR) of 10.5%. The
Oligonucleotide Synthesis Market CAGR 9.9% by 2035, Due To The Growing Demand Fo …
According to our latest market report "Oligonucleotide Synthesis Market by Application Area, Type of Product Synthesized, Type of Oligonucleotide Synthesized, Scale of Operation, Therapeutic Area, End-users, Company Size and Key Geographical Regions: Industry Trends and Global Forecasts, Till 2035", the global oligonucleotide synthesis market size is projected to reach USD 13.5 billion by 2035 from USD 4.8 billion in 2024, growing at a CAGR of 9.9% in the forecast period
Oligonucleotide Synthesis Market Outlook, 2030
The global oligonucleotide synthesis market is set to witness unprecedented growth in the coming decade, driven by advancements in biotechnology, increasing applications in genetic research, and rising demand for personalized medicine. According to market research, the global oligonucleotide synthesis market size was valued at USD 5.198 billion in 2020 and is projected to reach USD 26.09 billion by 2030, growing at a compound annual growth rate (CAGR) of 17.10% from
Antisense Oligonucleotide Therapeutics Market
Antisense Oligonucleotide Therapeutics Market worth $ 64.64 Billion by 2030 - Exclusive Report by Insight Analytics Insight Analytics Pvt. Ltd. announces the release of a market assessment report on the "Global Antisense Oligonucleotide Therapeutics Market- by Therapy (Monotherapy and Combination), Molecule Target Indication (DNA Molecule and RNA Molecule), Target Indication (Duchenne Muscular Atrophy, Spinal Muscular Atrophy, Familial Chylomicronemia Syndrome, Amyotrophic Lateral Sclerosis, Familial Partial Lipodystrophy, Hereditary Transthyretin-Mediated (hatter) Amyloidosis, Huntington's Disease
Oligonucleotide Therapy Market Transforming Healthcare: The Oligonucleotide Ther …
Oligonucleotide Therapy Market worth $19.92 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Oligonucleotide Therapy Market - (By Type (Antisense, Ribozymes, Aptamers, miRNA, CpG/Immunostimulatory, RNAi), By Application (Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney Diseases, Others), By End User (Hospitals, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According
Global Market Study on Oligonucleotide Synthesis: Custom Oligonucleotide Synthes …
Researchmoz added latest report "Global Market Study on Oligonucleotide Synthesis: Custom Oligonucleotide Synthesis Service Type Segment to Hold 70% Market Share by 2025". The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. Our new research report on the global oligonucleotide synthesis market gives a brief overview of the global market. The report includes projections on the global oligonucleotide synthesis